Lv3
350 积分 2025-01-16 加入
Genetic and epigenetic mechanisms of GPRC5D loss after anti-GPRC5D CAR T-cell therapy in multiple myeloma
6天前
已完结
Stem cell damage after chemotherapy- can we do better?
21天前
已完结
Making the diagnosis, the tools, and risk stratification: More than just BCR-ABL
21天前
已完结
A review of latest clinical practice guidelines for the management of cancer-associated thrombosis
21天前
已关闭
Molecular genetics of MDS/MPN overlap syndromes
21天前
已完结
Best practice & research clinical haematology: Screening for breast cancer in hodgkin lymphoma survivors
21天前
已关闭
IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model
24天前
已完结
EZH2 inhibition enhances T cell immunotherapies by inducing lymphoma immunogenicity and improving T cell function
24天前
已完结
The Effect of Lymphangiogenesis in Transplant Arteriosclerosis
24天前
已完结
FGF19/FGFR4-mediated elevation of ETV4 facilitates hepatocellular carcinoma metastasis by upregulating PD-L1 and CCL2
27天前
已完结
皖公网安备34019202002308
